Skip to main navigation Skip to search Skip to main content

Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion to Nulojix? (belatacept)-based Immunosuppression

Project: Research

Project Details

StatusFinished
Effective start/end date11/5/1311/30/20

Funding

  • ICON Clinical Research: $163,314.70